No Data
No Data
The USA will announce the selection list for the third round of drug price negotiations in February next year.
The USA Medical Insurance and Medical Assistance Services Center (CMS) plans to list up to 15 drugs selected for the third round of price negotiations before February 1, 2026, and is seeking public opinion.
"Do not sell if prices do not drop"! Trump enforces a cap on the minimum drug prices for developed countries, but a litigation battle may 'replay'.
① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.
The "Most-Favored-Nation Pricing" policy for Trump Medicine has been issued: benchmarked against developed countries, complete the Quote within 30 days.
① This policy aims to align prescription drug pricing in the USA with that of "Other developed countries". Trump has requested that the Quote be completed within 30 days; ② The scope of affected Pharmaceuticals is still unclear, and the White House has stated that the government will pay special attention to drugs that have the "largest price differences and highest spending"; ③ Trump had implemented a similar policy before the end of his last term, but it was blocked by the courts and ultimately fell through.
Exact Sciences Earns 2025 Great Place To Work Certification
Trump strikes again on drug prices: the most-favored-nation model is making a comeback, which pharmaceutical giants are feeling the most pain?
How to negotiate a price and what impact does it have?
Trump plans to promote a "Global minimum price" drug reform order, which could reduce U.S. drug prices by up to 80%.
Trump plans to sign an executive order to lower the cost of pharmaceuticals in the USA, ensuring that Americans do not pay more for drugs than the lowest-priced country.